Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

M.J. Kempers; R.P. Kuiper; C.W. Ockeloen; P.O. Chappuis; P. Hutter; N. Rahner; H.K. Schackert; V. Steinke; E. Holinski-Feder; M. Morak; M. Kloor; R. Büttner; E.T. Verwiel; J.H. van Krieken; I.D.. Nagtegaal; M. Goossens; R.S. van der Post; R.C. Niessen; R.H. Sijmons; I. Kluijt; F.B. Hogervorst; E.M. Leter; J.J. Gille; C.M. Aalfs; E.J. Redeker; X et al.; B.P.M. van Nesselrooij; M.E. van Gijn

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

Translated title of the contribution: Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

M.J. Kempers, R.P. Kuiper, C.W. Ockeloen, P.O. Chappuis, P. Hutter, N. Rahner, H.K. Schackert, V. Steinke, E. Holinski-Feder, M. Morak, M. Kloor, R. Büttner, E.T. Verwiel, J.H. van Krieken, I.D.. Nagtegaal, M. Goossens, R.S. van der Post, R.C. Niessen, R.H. Sijmons, I. KluijtF.B. Hogervorst, E.M. Leter, J.J. Gille, C.M. Aalfs, E.J. Redeker, X et al., B.P.M. van Nesselrooij, M.E. van Gijn

Research output: Contribution to journal › Article › Academic

Translated title of the contribution	Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Original language	Undefined/Unknown
Pages (from-to)	49-55
Number of pages	7
Journal	LANCET ONCOLOGY
Volume	12
Issue number	1
Publication status	Published - 2011

Cite this

Kempers, M. J., Kuiper, R. P., Ockeloen, C. W., Chappuis, P. O., Hutter, P., Rahner, N., Schackert, H. K., Steinke, V., Holinski-Feder, E., Morak, M., Kloor, M., Büttner, R., Verwiel, E. T., van Krieken, J. H., Nagtegaal, I. D., Goossens, M., van der Post, R. S., Niessen, R. C., Sijmons, R. H., ... van Gijn, M. E. (2011). Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. LANCET ONCOLOGY, 12(1), 49-55.

@article{2c3b9c9c5792477c8b34a7fc32e1ff72,

title = "Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study",

author = "M.J. Kempers and R.P. Kuiper and C.W. Ockeloen and P.O. Chappuis and P. Hutter and N. Rahner and H.K. Schackert and V. Steinke and E. Holinski-Feder and M. Morak and M. Kloor and R. B{\"u}ttner and E.T. Verwiel and {van Krieken}, J.H. and I.D.. Nagtegaal and M. Goossens and {van der Post}, R.S. and R.C. Niessen and R.H. Sijmons and I. Kluijt and F.B. Hogervorst and E.M. Leter and J.J. Gille and C.M. Aalfs and E.J. Redeker and {et al.}, X and {van Nesselrooij}, B.P.M. and {van Gijn}, M.E.",

year = "2011",

language = "Undefined/Unknown",

volume = "12",

pages = "49--55",

journal = "LANCET ONCOLOGY",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "1",

}

Kempers, MJ, Kuiper, RP, Ockeloen, CW, Chappuis, PO, Hutter, P, Rahner, N, Schackert, HK, Steinke, V, Holinski-Feder, E, Morak, M, Kloor, M, Büttner, R, Verwiel, ET, van Krieken, JH, Nagtegaal, ID, Goossens, M, van der Post, RS, Niessen, RC, Sijmons, RH, Kluijt, I, Hogervorst, FB, Leter, EM, Gille, JJ, Aalfs, CM, Redeker, EJ, et al., X, van Nesselrooij, BPM & van Gijn, ME 2011, 'Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study', LANCET ONCOLOGY, vol. 12, no. 1, pp. 49-55.

TY - JOUR

T1 - Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

AU - Kempers, M.J.

AU - Kuiper, R.P.

AU - Ockeloen, C.W.

AU - Chappuis, P.O.

AU - Hutter, P.

AU - Rahner, N.

AU - Schackert, H.K.

AU - Steinke, V.

AU - Holinski-Feder, E.

AU - Morak, M.

AU - Kloor, M.

AU - Büttner, R.

AU - Verwiel, E.T.

AU - van Krieken, J.H.

AU - Nagtegaal, I.D..

AU - Goossens, M.

AU - van der Post, R.S.

AU - Niessen, R.C.

AU - Sijmons, R.H.

AU - Kluijt, I.

AU - Hogervorst, F.B.

AU - Leter, E.M.

AU - Gille, J.J.

AU - Aalfs, C.M.

AU - Redeker, E.J.

AU - et al., X

AU - van Nesselrooij, B.P.M.

AU - van Gijn, M.E.

PY - 2011

Y1 - 2011

M3 - Article

SN - 1470-2045

VL - 12

SP - 49

EP - 55

JO - LANCET ONCOLOGY

JF - LANCET ONCOLOGY

IS - 1

ER -